1. CpG postconditioning after reperfused myocardial infarction is associated with modulated inflammation, less apoptosis, and better left ventricular function
- Author
-
Shuijing Wu, Vanessa Marggraf, Oliver Dewald, Markus Velten, Georg D. Duerr, Max Lukas Schneider, Olaf Boehm, Georg Baumgarten, Hendrik Treede, Se-Chan Kim, Christina Weisheit, Stilla Frede, and Luise Verfuerth
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Physiology ,medicine.medical_treatment ,Anti-Inflammatory Agents ,Myocardial Infarction ,Apoptosis ,Myocardial Reperfusion Injury ,Inflammation ,030204 cardiovascular system & hematology ,MMP8 ,Ventricular Function, Left ,Proinflammatory cytokine ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Fibrosis ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Ischemic Postconditioning ,Cells, Cultured ,Myosin Heavy Chains ,business.industry ,Macrophages ,Myocardium ,TLR9 ,Tissue Inhibitor of Metalloproteinases ,Tissue inhibitor of metalloproteinase ,medicine.disease ,Mice, Inbred C57BL ,030104 developmental biology ,Endocrinology ,Cytokine ,Oligodeoxyribonucleotides ,CpG site ,Toll-Like Receptor 9 ,Cytokines ,Female ,Collagen ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Heme Oxygenase-1 ,Injections, Intraperitoneal - Abstract
Postconditioning attenuates inflammation and fibrosis in myocardial infarction (MI). The aim of this study was to investigate whether postconditioning with the cytosine-phosphate-guanine (CpG)-containing Toll-like receptor-9 (TLR9) ligand 1668-thioate (CpG) can modulate inflammation and remodeling in reperfused murine MI. Thirty minutes of left descending coronary artery (LAD) occlusion was conducted in 12-wk-old C57BL/6 mice. Mice were treated with CpG intraperitoneally 5 min before reperfusion. The control group received PBS; the sham group did not undergo ischemia. M-mode echocardiography (3, 7, and 28 days) and Millar left ventricular (LV) catheterization were performed (7 and 28 days) before the hearts were excised and harvested for immunohistochemical (6 h, 24 h, 3 days, 7 days, and 28 days), gene expression (6 h, 24 h, and 3 days; Taqman RT-qPCR), protein, and FACS analysis (24 h and 3 days). Mice treated with CpG showed significantly better LV function after 7 and 28 days of reperfusion. Protein and mRNA expressions of proinflammatory and anti-inflammatory cytokines were significantly induced after CpG treatment. Histology revealed fewer macrophages in CpG mice after 24 h, confirmed by FACS analysis with a decrease in both classically M1- and alternative M2a-monocytes. CpG treatment reduced apoptosis and cardiomyocyte loss and was associated with induction of adaptive mechanisms, e.g., of heme-oxigenase-1 and β-/α-myosin heavy chain (MHC) ratio. Profibrotic markers collagen type Iα (Col-Ια) and Col-III induction was abrogated in CpG mice, accompanied by fewer myofibroblasts. This led to the formation of a smaller scar. Differential matrix metalloproteinase (MMP)/tissue inhibitor of metalloproteinase (TIMP) expression contributed to attenuated remodeling in CpG, resulting in preserved cardiac function in a Toll-like receptor 1- and TLR9-dependent manner. Our study suggests a cardioprotective mechanism of CpG postconditioning, involving Toll-like receptor-driven modulation of inflammation. This is followed by attenuated remodeling and preserved LV function.NEW & NOTEWORTHY Cytosine-phosphate-guanine (CpG) postconditioning seems to mediate inflammation via Toll-like receptor-1 and Toll-like receptor-9 signaling. Enhanced cytokine and chemokine expressions are partly attenuated by IL-10 and matrix metalloproteinase-8 (MMP8) induction, being associated with lower macrophage infiltration and M1-monocyte differentiation. Furthermore, switch from α- to β-MHC and balanced MMP/TIMP expression led to lesser cardiomyocyte apoptosis, smaller scar size, and preserved cardiac function. Data of pharmacological postconditioning have been widely disappointing to date. Our study suggests a new pathway promoting myocardial postconditioning via Toll-like receptor activation.
- Published
- 2020
- Full Text
- View/download PDF